Aakaar Medical Technologies share price
NSE: AAKAARPersonal Products
Aakaar Medical Technologies Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2025 · Issue price ₹72
Last close ₹71.00up ₹1.05 (1.50%)
Share price at the NSE close on 29 Oct 2026. Previous close ₹69.95.
29 Oct: open ₹71.00, high ₹71.00, low ₹71.00
52-week range of traded prices to 29 Oct 2026
₹46.00Low, 27 Mar 2026₹89.95High, 10 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹101 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.16
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.84
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.34
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,600100.0% delivered
Results
Standalone; ₹ crore.Aakaar Medical Technologies half-yearly results
Half year to Sep 2026, against the half year before
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹44 Crup 5.01%
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹3.54 Crdown 52.29%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 8.1%
Revenue by half year
Peak revenue ₹44 Cr, half year to Sep 2026; lowest ₹25 Cr, half year to Sep 2025
Net profit by half year, a loss in red
- Net profit
- Loss
A loss in 1 of the 3 half years shown
| ₹ crore | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
| Revenue | 25.3 | 41.6 | 43.7 |
| Net profit | −0.8 | 7.4 | 3.5 |
| Net margin | −3.1% | 17.8% | 8.1% |
Standalone. The 3 half years from Sep 2025, the first on record. The latest is shaded.
Year to Mar 2026
- Revenue
- ₹67 Cr
- Net profit
- ₹6.64 Cr
- Net margin
- 9.9%
| ₹ crore | Mar 2026 |
|---|---|
| Revenue | 67.0 |
| Net profit | 6.6 |
| Net margin | 9.9% |
Standalone. Years to March.
Business segments
Share of revenue, year to Mar 2026, standalone.Segment revenue and profit
- Aesthetic ProductsAesthetic Products, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹59.6 Cr89.0%
- Aesthetic Devices & Device ConsumablesAesthetic Devices & Device Consumables, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹7.4 Cr11.0%
Aakaar Medical Technologies competitors and peers
Personal Care, 21 listed companies, priced on 30 Oct 2026. The table lists the 8 companies closest to Aakaar Medical Technologies in market cap. Aakaar Medical Technologies' own figures are from its last trade, on 29 Oct 2026. 1 company in the table last traded before then: its row is priced on its last trade.FMCG companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Recode StudiosRECODE | 407 | 36.34 | – | – | – | 56.1% | – | 0.07% |
 Radix Industries (India)RADIXIND | 227 | 77.45 | 9.73 | −7.0% | +7.6% | 13.3% | 13.9% | 0.00% |
 Macobs TechnologiesMACOBSTECH | 192 | 66.12 | 4.62 | – | – | 8.3% | – | 0.00% |
 H. R. Hygiene ProductsHRHYGIENE | 137 | – | – | – | – | – | – | 0.00% |
 Thrive Future HabitatsTHRIVE | 88 | – | 1.66 | −29.8% | – | −5.3% | −6.8% | 0.00% |
 JHS Svendgaard LaboratoriesJHS | 70 | – | 0.40 | +19.4% | – | −1.1% | −2.3% | 0.00% |
 RavelcareRAVEL | 61 | 11.82 | 1.63 | – | – | 13.8% | – | 0.00% |
 Medistep HealthcareMEDISTEP | 28 | 4.63 | 0.73 | – | – | 15.8% | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Aakaar Medical Technologies announcements
Oct 2026
30 Oct · Results
28 Oct · Analysts
17 Oct · Analysts
Sep 2026
16 Sep · Analysts
8 Sep · Analysts
Aakaar Medical Technologies share price by year
Each calendar year to 2025.Aakaar Medical Technologies share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 73.75 | – | 101.35 | 63.00 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 27 Jun 2025.
Recent sessions
The 9 trading days to 28 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 28 Oct 2026 | 65.00 | 69.95 | 65.00 | 69.95 | 65.62 | 12,800 | 87.5% |
| 27 Oct 2026 | 66.75 | 66.75 | 66.75 | 66.75 | 66.75 | 1,600 | 100.0% |
| 26 Oct 2026 | 63.65 | 63.65 | 63.65 | 63.65 | 63.65 | 1,600 | 100.0% |
| 23 Oct 2026 | 64.05 | 64.05 | 63.80 | 63.80 | 63.92 | 3,200 | 100.0% |
| 22 Oct 2026 | 67.05 | 67.15 | 67.05 | 67.15 | 67.08 | 6,400 | 100.0% |
| 21 Oct 2026 | 65.00 | 65.00 | 65.00 | 65.00 | 65.00 | 1,600 | 100.0% |
| 19 Oct 2026 | 71.00 | 71.00 | 67.45 | 67.45 | 70.58 | 27,200 | 100.0% |
| 16 Oct 2026 | 71.00 | 71.00 | 71.00 | 71.00 | 71.00 | 14,400 | 100.0% |
| 14 Oct 2026 | 69.30 | 71.00 | 69.30 | 70.95 | 70.74 | 12,800 | 87.5% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- AAKAAR
- ISIN
- INE1GYP01013
- Industry
- Personal Products